Related Experiment Video
Updated: Mar 29, 2026

Measuring Local Anaphylaxis in Mice
Published on: October 14, 2014
Hemocoagulase agkistrodon-induced anaphylactic shock: A case report and literature review
Abstract:
Hemocoagulase agkistrodon for injection is the national first-class new drug of China with good hemostatic function and safety for capillary hemorrhage in abdominal incision of surgical patients. Adverse drug reactions (ADRs) to hemocoagulase agkistrodon are rarely reported. In this paper, we describe a case of a 41-year-old woman who developed anaphylactic shock attributed to hemocoagulase agkistrodon before colon cancer surgery. Based on the Naranjo ADR probability score, a "probable" cause and effect relationship existed for this case. Although the cause of anaphylactic reaction (hemocoagulase or excipient) and exact mechanism of hemocoagulase agkistrodon-induced anaphylactic reaction are unknown, attention should be drawn to potential ADRs in clinical use.
Related Concept Videos
Allergic Reactions: Anaphylaxis
Allergic Reactions
Hypersensitivity Reactions: Immune-Complex Reactions
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Drug Toxicity: Allergic Reactions
Hypersensitivity Reactions: Cytolytic Reactions

